Eppie Brown

636 total citations
12 papers, 512 citations indexed

About

Eppie Brown is a scholar working on Surgery, Pathology and Forensic Medicine and Psychiatry and Mental health. According to data from OpenAlex, Eppie Brown has authored 12 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Pathology and Forensic Medicine and 5 papers in Psychiatry and Mental health. Recurrent topics in Eppie Brown's work include Migraine and Headache Studies (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Trigeminal Neuralgia and Treatments (4 papers). Eppie Brown is often cited by papers focused on Migraine and Headache Studies (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Trigeminal Neuralgia and Treatments (4 papers). Eppie Brown collaborates with scholars based in United States and Colombia. Eppie Brown's co-authors include C.A. Endersby, John Talbot, R.N. Smith, P.A. Fowler, M. Thomas, V. Pfaffenrath, W. Feniuk, N. Baber, Michael Jackson and J LANCE and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and The Journal of Urology.

In The Last Decade

Eppie Brown

10 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eppie Brown United States	7	369	251	226	138	103	12	512
Marije Reekers Netherlands	6	246 0.7×	139 0.6×	138 0.6×	63 0.5×	38 0.4×	8	336
Stefano Viola Italy	8	234 0.6×	170 0.7×	74 0.3×	30 0.2×	27 0.3×	20	314
Micaela Forshaw United States	4	389 1.1×	248 1.0×	148 0.7×	35 0.3×	11 0.1×	7	428
G Gamberini Italy	10	212 0.6×	174 0.7×	182 0.8×	64 0.5×	33 0.3×	20	434
Bojana Žvan Slovenia	14	141 0.4×	47 0.2×	60 0.3×	34 0.2×	136 1.3×	40	466
F Titus Spain	10	237 0.6×	135 0.5×	119 0.5×	74 0.5×	15 0.1×	25	438
Jacob D. Greisman United States	6	200 0.5×	101 0.4×	55 0.2×	67 0.5×	18 0.2×	19	280
Júlia Pareja Spain	11	201 0.5×	183 0.7×	96 0.4×	18 0.1×	92 0.9×	22	353
Ted E Roberts Canada	5	259 0.7×	144 0.6×	119 0.5×	75 0.5×	3 0.0×	7	415
Hans van Suijlekom Netherlands	8	65 0.2×	131 0.5×	118 0.5×	101 0.7×	22 0.2×	14	324

Countries citing papers authored by Eppie Brown

Since Specialization

Citations

This map shows the geographic impact of Eppie Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eppie Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eppie Brown more than expected).

Fields of papers citing papers by Eppie Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eppie Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eppie Brown. The network helps show where Eppie Brown may publish in the future.

Co-authorship network of co-authors of Eppie Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Eppie Brown. A scholar is included among the top collaborators of Eppie Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eppie Brown. Eppie Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Jayram, Gautam, Neal D. Shore, Jacqueline Zummo, et al.. (2025). ADVANCED-2: PHASE 2 OPEN-LABEL STUDY TO EVALUATE SAFETY AND ANTI-TUMOR ACTIVITY OF INTRAVESICAL INSTILLATION OF TARA-002 IN ADULTS WITH HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER. Urologic Oncology Seminars and Original Investigations. 43(3). 48–48.

Jayram, Gautam, Eugene V. Kramolowsky, William Tabayoyong, et al.. (2025). IP02-40 PRELIMINARY ANTI-TUMOR ACTIVITY AND SAFETY RESULTS FROM ADVANCED-2: A PHASE 2 OPEN-LABEL STUDY OF INTRAVESICAL TARA-002 IN ADULTS WITH HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER. The Journal of Urology. 213(5S). 1 indexed citations

Lyon, Timothy D., William Tabayoyong, Edward M. Messing, et al.. (2024). PHASE 1B/2 DOSE-EXPANSION, OPEN-LABEL STUDY TO EVALUATE SAFETY AND ANTI-TUMOR ACTIVITY OF INTRAVESICAL INSTILLATION OF TARA-002 IN ADULTS WITH HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER. Urologic Oncology Seminars and Original Investigations. 42. S64–S65. 1 indexed citations

Bandari, Jathin, Gautam Jayram, William Tabayoyong, et al.. (2024). ADVANCED-1: PHASE 1A DOSE-FINDING, OPEN-LABEL STUDY TO EVALUATE SAFETY AND TOXICITY OF INTRAVESICAL INSTILLATION OF TARA-002 IN ADULTS WITH HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER. Urologic Oncology Seminars and Original Investigations. 42. S61–S61.

Bandari, Jathin, et al.. (2022). Phase 1a/b safety study of intravesical instillation of TARA-002 in adults with high-grade non-muscle invasive bladder cancer (ADVANCED-1).. Journal of Clinical Oncology. 40(16_suppl). TPS4620–TPS4620. 6 indexed citations

Samara, Emil, Peter Winkle, P. Gómez Pardo, et al.. (2013). Pharmacokinetics of dalfampridine extended release 7.5‐mg tablets in healthy subjects and individuals with mild and moderate renal impairment: An open‐label study. The Journal of Clinical Pharmacology. 54(1). 53–60. 6 indexed citations

Kini, Annapoorna, Jonathan D. Marmur, Subhash Kini, et al.. (1999). Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course. Journal of the American College of Cardiology. 34(3). 663–671. 105 indexed citations

Brown, Eppie, C.A. Endersby, R.N. Smith, & John Talbot. (1991). The Safety and Tolerability of Sumatriptan: An Overview. European Neurology. 31(5). 339–344. 96 indexed citations

Humphrey, P.P.A., W. Feniuk, A.S. Marriott, et al.. (1991). Self-Treatment of Acute Migraine with Subcutaneous Sumatriptan Using an Auto-Injector Device. European Neurology. 31(5). 323–331. 72 indexed citations

10.

Humphrey, P.P.A., W. Feniuk, A.S. Marriott, et al.. (1991). Evaluation of a Multiple-Dose Regimen of Oral Sumatriptan for the Acute Treatment of Migraine. European Neurology. 31(5). 306–313. 76 indexed citations

11.

Humphrey, P.P.A., W. Feniuk, A.S. Marriott, et al.. (1991). A Placebo-Controlled Study of Intranasal Sumatriptan for the Acute Treatment of Migraine. European Neurology. 31(5). 332–338. 51 indexed citations

12.

Humphrey, P.P.A., W. Feniuk, A.S. Marriott, et al.. (1991). Sumatriptan An Oral Dose-Defining Study. European Neurology. 31(5). 300–305. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact